Home / SLXNW : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does SLXNW make money? Does SLXNW have pricing power? What's the Earnings Whisper? Will SLXNW profit more as the business scales? What is SLXNW's management track record? Is SLXNW's current price justified?

Silexion Therapeutics Ltd.

$0.01 -$0.03 (-70.00%)

NASDAQ · 10 Sep 2026 15:56 UTC

Previous Close

$0.01

Day Range

$0.01$0.03

Year Range

$0.01$0.03

Market Cap

6.56K

AVG Volume

41.33K

Trailing/Forward PE

-0.01/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-18

Primary Exchange

NASDAQ

Net Income (USD)

SLXNW Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-3.55M
26 Q1	-2.73M
25 Q4	-4.41M
25 Q3	-3.26M
25 Q2	-2.5M
25 Q1	-1.74M
24 Q4	-1.75M
24 Q3	-11.85M
24 Q2	-1.47M
24 Q1	-1.37M

Operating Income (USD)

SLXNW Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-3.68M
26 Q1	-2.75M
25 Q4	18.86M
25 Q3	-3.29M
25 Q2	-2.28M
25 Q1	-1.65M
24 Q4	-1.9M
24 Q3	-8.04M
24 Q2	-1.39M
24 Q1	-1.25M

EBITDA (USD)

SLXNW EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-3.68M
26 Q1	-2.73M
25 Q4	-4.4M
25 Q3	-3.26M
25 Q2	-2.5M
25 Q1	-1.72M
24 Q4	-1.75M
24 Q3	-11.78M
24 Q2	-1.48M
24 Q1	-1.41M

Cash Flows (USD)

SLXNW Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-2.92M
26 Q1	-3.65M
25 Q4	-3.02M
25 Q3	-2.84M
25 Q2	-2.51M
25 Q1	-2.46M
24 Q4	-2.93M
24 Q3	-2.67M
24 Q2	-1.06M
24 Q1	-1.76M

EPS (USD)

SLXNW EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-5.17
26 Q1	-8.46
25 Q4	-14.11
25 Q3	-28.8
25 Q2	-43.19
25 Q1	-38.39
24 Q4	-1.9
24 Q3	-11.5
24 Q2	-0.3
24 Q1	-12.7

Expenses (USD)

SLXNW Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	3.68M
26 Q1	2.75M
25 Q4	4.41M
25 Q3	3.29M
25 Q2	2.28M
25 Q1	1.65M
24 Q4	1.9M
24 Q3	8.03M
24 Q2	1.38M
24 Q1	1.25M

Cash & Debt (USD)

SLXNW Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	2.23M
26 Q1	2.41M
25 Q4	5.99M
25 Q3	9.24M
25 Q2	3.47M
25 Q1	6.15M
24 Q4	1.19M
24 Q3	1.97M
24 Q2	1.7M
24 Q1	2.78M

Debt ratios

SLXNW Debt ratios by quarter
Period	Debt ratios
26 Q2	0.06
26 Q1	0.15
25 Q4	0.46
25 Q3	0.95
25 Q2	-0.01
25 Q1	0.16
24 Q4	-0.2
24 Q3	-0.14
24 Q2	0.3
24 Q1	0.71

Return on Capital

SLXNW Return on Capital by quarter
Period	Return on Capital
26 Q2	-8070.45%
26 Q1	-939.18%
25 Q4	-169.5%
25 Q3	-46.75%
25 Q2	-2085.83%
25 Q1	-67.09%
24 Q4	43.8%
24 Q3	258.81%
24 Q2	9.88%
24 Q1	10.21%

Shares Outstanding

SLXNW Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	687.35K
26 Q1	323.04K
25 Q4	312.67K
25 Q3	113.27K
25 Q2	57.95K
25 Q1	45.19K
24 Q4	924.36K
24 Q3	647.57K
24 Q2	430K
24 Q1	111.73K

Book Value Per Share (USD)

SLXNW Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.06
26 Q1	0.9
25 Q4	8.33
25 Q3	61.6
25 Q2	2.07
25 Q1	57.22
24 Q4	-4.32
24 Q3	-7.07
24 Q2	-34.66
24 Q1	-120.36

Total Assets (USD)

SLXNW Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	4.25M
26 Q1	4.6M
25 Q4	7.21M
25 Q3	11.61M
25 Q2	5.8M
25 Q1	8.31M
24 Q4	2.86M
24 Q3	3.09M
24 Q2	2.52M
24 Q1	3.58M

Employee Count

SLXNW Employee Count by quarter
Period	Employee Count
2025	13
2024	50K

Free Cash Flow Yield

SLXNW Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-154587.83%
Sep 26	-129191.26%
Aug 26	-129191.26%
Aug 26	-120578.51%
Aug 26	-142415.56%
Aug 26	-169835.08%
Jul 26	-185969.41%
Jul 26	-79986.84%
Jul 26	-74836.78%
Jul 26	-148775.53%
Jul 26	-148182.8%
Jun 26	-111358.93%
Jun 26	-137246.8%
Jun 26	-111358.93%
Jun 26	-103893.52%
May 26	-224059.53%
May 26	-224059.53%
May 26	-309949.02%
May 26	-230875.43%
May 26	-217807.01%
Apr 26	-133197.36%
Apr 26	-167301.04%
Apr 26	-135809.08%
Apr 26	-247366.53%
Mar 26	-164129.45%
Mar 26	-247366.53%
Mar 26	-776939.04%
Mar 26	-283792.1%
Feb 26	-275542.33%
Feb 26	-270818.75%
Feb 26	-290756.33%
Feb 26	-244926.52%
Jan 26	-246840.01%
Jan 26	-270047.19%
Jan 26	-256179.9%
Jan 26	-249438.32%
Jan 26	-243042.47%
Dec 25	-284644.33%
Dec 25	-271594.73%
Dec 25	-270047.19%
Dec 25	-287232.01%
Nov 25	-313862.79%
Nov 25	-313862.79%
Nov 25	-287232.01%
Nov 25	-548958.67%
Oct 25	-405009.51%
Oct 25	-365972.45%
Oct 25	-472161.35%
Oct 25	-514842.6%
Oct 25	-455635.7%
Sep 25	-510516.19%
Sep 25	-523719.19%
Sep 25	-511950.22%
Sep 25	-559062.21%
Aug 25	-540012.68%
Aug 25	-607514.26%
Aug 25	-613671.43%
Aug 25	-770131.95%
Aug 25	-618940.4%
Jul 25	-509531.75%
Jul 25	-492133.1%
Jul 25	-473649.23%
Jul 25	-505700.68%
Jun 25	-500681.32%
Jun 25	-366862.86%
Jun 25	-318261.44%
Jun 25	-291161%
May 25	-411784.84%
May 25	-448387.94%
May 25	-489744.11%
May 25	-18972.69%
May 25	-12390.33%
Apr 25	-18250.28%
Apr 25	-17997.81%
Apr 25	-17513.25%
Apr 25	-15178.15%
Mar 25	-13179.29%
Mar 25	-16527.93%
Mar 25	-25720.32%
Mar 25	-26218.14%
Feb 25	-27092.07%
Feb 25	-33378.33%
Feb 25	-24407.27%
Feb 25	-24352.43%
Jan 25	-19584.4%
Jan 25	-41894.96%
Jan 25	-34006.79%
Jan 25	-64761.93%
Dec 24	-58895.81%
Dec 24	-65117.35%
Dec 24	-94507.24%
Dec 24	-81276.22%
Nov 24	-56052.57%
Nov 24	-64504.94%
Nov 24	-77039.07%
Nov 24	-31062.35%
Nov 24	-24880.98%
Oct 24	-49699.77%
Oct 24	-49699.77%
Oct 24	-49575.83%

Price to Book

SLXNW Price to Book by quarter
Period	Price to Book
Sep 26	0.18
Sep 26	0.22
Aug 26	0.22
Aug 26	0.23
Aug 26	0.2
Aug 26	0.02
Jul 26	0.02
Jul 26	0.05
Jul 26	0.06
Jul 26	0.03
Jul 26	0.03
Jun 26	0.04
Jun 26	0.03
Jun 26	0.04
Jun 26	0.04
May 26	0.02
May 26	0.02
May 26	0.01
May 26	0
May 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Dec 25	0
Dec 25	0
Dec 25	0
Dec 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Nov 25	0.02
Oct 25	0.02
Oct 25	0.02
Oct 25	0.02
Oct 25	0.02
Oct 25	0.02
Sep 25	0.02
Sep 25	0.02
Sep 25	0.02
Sep 25	0.02
Aug 25	0.02
Aug 25	0.01
Aug 25	0.01
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jun 25	0
Jun 25	0
Jun 25	0
Jun 25	0
May 25	0
May 25	0
May 25	0

No video analysis for this stock yet. Request one from our team.

AI Analysis

Silexion Therapeutics Ltd.

Video analysis: SLXNW

Similar companies